Isolation of immunosuppressive phospholipids from marine bacteria

Yasuhiro Kohama, Toshio Suda, Kentaro Iida, Tsuyoshi Ishii, Tsutomu Mimura, Kazuo Kamimura, Yukiho Yamaoka, Hiroshi Tsujibo, Yoshihiko Inamori, Chiaki Imada, Yoshiro Okami

Research output: Contribution to journalArticle

Abstract

Lipid extracts of marine bacterial strains isolated from seawater and sediments from Japanese coasts were screened for inhibition of mouse mixed lymphocyte reaction (MLR). Two strains, Bacillus sp. SP22 and Alteromonas sp. RS103, were found to contain appreciable MLR-inhibitory activity. Two active components, 22I and 103I, were purified from the extracts of Bacillus sp. SP22 and Alteromonas sp. RS103, respectively, by successive silica gel column chromatographies. The structure of 22I was estimated to be phosphatidic acid containing saturated isofatty acids (C14:0-C17:0). 103I consisted of phosphatidylglycerol with saturated isofatty acids (C15:0-C18:0). 22I (0.01-1 μg/ml)and 103I (1-10 μg/ml) significantly inhibited MLR in a dose-dependent manner but did not inhibit mitogen-induced proliferation of lymphocytes, unlike cyclosporin A. They did not show any cytotoxicity against mouse splenocytes. L-α-Phosphatidic acid dipalmitoyl, L-α-phosphatidic acid prepared from egg yolk lecithin, and L-α-phosphatidylglycerol dipalmitoyl showed no MLR-inhibitory activity. Isofatty acid-containing phospholipids decreased plasma membrane fluidity of adherent splenocytes and lymphoid neoplasma cell line P388-D1 cells at concentrations with MLR-inhibitory activity, while nonadherent splenocytes were not affected. Daily subcutaneous injection of 221 or 1031 (1 mg/kg/day) resulted in significant suppression of skin-graft rejection between mice with histocompatibility differences. The results suggest that isofatty acid-containing phospholipids suppress the immune responses via the direct action on adherent splenocytes such as macrophages.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalJournal of Marine Biotechnology
Volume4
Issue number3
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Mixed Lymphocyte Culture Test
Lymphocytes
Immunosuppressive Agents
Phospholipids
Bacteria
Alteromonas
Phosphatidylglycerols
Phosphatidic Acids
Acids
Bacillus
Bacilli
Membrane Fluidity
Egg Yolk
Histocompatibility
Lecithins
Silica Gel
Graft Rejection
Seawater
Subcutaneous Injections
Column chromatography

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kohama, Y., Suda, T., Iida, K., Ishii, T., Mimura, T., Kamimura, K., ... Okami, Y. (1996). Isolation of immunosuppressive phospholipids from marine bacteria. Journal of Marine Biotechnology, 4(3), 131-137.

Isolation of immunosuppressive phospholipids from marine bacteria. / Kohama, Yasuhiro; Suda, Toshio; Iida, Kentaro; Ishii, Tsuyoshi; Mimura, Tsutomu; Kamimura, Kazuo; Yamaoka, Yukiho; Tsujibo, Hiroshi; Inamori, Yoshihiko; Imada, Chiaki; Okami, Yoshiro.

In: Journal of Marine Biotechnology, Vol. 4, No. 3, 1996, p. 131-137.

Research output: Contribution to journalArticle

Kohama, Y, Suda, T, Iida, K, Ishii, T, Mimura, T, Kamimura, K, Yamaoka, Y, Tsujibo, H, Inamori, Y, Imada, C & Okami, Y 1996, 'Isolation of immunosuppressive phospholipids from marine bacteria', Journal of Marine Biotechnology, vol. 4, no. 3, pp. 131-137.
Kohama Y, Suda T, Iida K, Ishii T, Mimura T, Kamimura K et al. Isolation of immunosuppressive phospholipids from marine bacteria. Journal of Marine Biotechnology. 1996;4(3):131-137.
Kohama, Yasuhiro ; Suda, Toshio ; Iida, Kentaro ; Ishii, Tsuyoshi ; Mimura, Tsutomu ; Kamimura, Kazuo ; Yamaoka, Yukiho ; Tsujibo, Hiroshi ; Inamori, Yoshihiko ; Imada, Chiaki ; Okami, Yoshiro. / Isolation of immunosuppressive phospholipids from marine bacteria. In: Journal of Marine Biotechnology. 1996 ; Vol. 4, No. 3. pp. 131-137.
@article{05418082c32445209fe8ffb2bb631664,
title = "Isolation of immunosuppressive phospholipids from marine bacteria",
abstract = "Lipid extracts of marine bacterial strains isolated from seawater and sediments from Japanese coasts were screened for inhibition of mouse mixed lymphocyte reaction (MLR). Two strains, Bacillus sp. SP22 and Alteromonas sp. RS103, were found to contain appreciable MLR-inhibitory activity. Two active components, 22I and 103I, were purified from the extracts of Bacillus sp. SP22 and Alteromonas sp. RS103, respectively, by successive silica gel column chromatographies. The structure of 22I was estimated to be phosphatidic acid containing saturated isofatty acids (C14:0-C17:0). 103I consisted of phosphatidylglycerol with saturated isofatty acids (C15:0-C18:0). 22I (0.01-1 μg/ml)and 103I (1-10 μg/ml) significantly inhibited MLR in a dose-dependent manner but did not inhibit mitogen-induced proliferation of lymphocytes, unlike cyclosporin A. They did not show any cytotoxicity against mouse splenocytes. L-α-Phosphatidic acid dipalmitoyl, L-α-phosphatidic acid prepared from egg yolk lecithin, and L-α-phosphatidylglycerol dipalmitoyl showed no MLR-inhibitory activity. Isofatty acid-containing phospholipids decreased plasma membrane fluidity of adherent splenocytes and lymphoid neoplasma cell line P388-D1 cells at concentrations with MLR-inhibitory activity, while nonadherent splenocytes were not affected. Daily subcutaneous injection of 221 or 1031 (1 mg/kg/day) resulted in significant suppression of skin-graft rejection between mice with histocompatibility differences. The results suggest that isofatty acid-containing phospholipids suppress the immune responses via the direct action on adherent splenocytes such as macrophages.",
author = "Yasuhiro Kohama and Toshio Suda and Kentaro Iida and Tsuyoshi Ishii and Tsutomu Mimura and Kazuo Kamimura and Yukiho Yamaoka and Hiroshi Tsujibo and Yoshihiko Inamori and Chiaki Imada and Yoshiro Okami",
year = "1996",
language = "English",
volume = "4",
pages = "131--137",
journal = "Journal of Marine Biotechnology",
issn = "0941-2905",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Isolation of immunosuppressive phospholipids from marine bacteria

AU - Kohama, Yasuhiro

AU - Suda, Toshio

AU - Iida, Kentaro

AU - Ishii, Tsuyoshi

AU - Mimura, Tsutomu

AU - Kamimura, Kazuo

AU - Yamaoka, Yukiho

AU - Tsujibo, Hiroshi

AU - Inamori, Yoshihiko

AU - Imada, Chiaki

AU - Okami, Yoshiro

PY - 1996

Y1 - 1996

N2 - Lipid extracts of marine bacterial strains isolated from seawater and sediments from Japanese coasts were screened for inhibition of mouse mixed lymphocyte reaction (MLR). Two strains, Bacillus sp. SP22 and Alteromonas sp. RS103, were found to contain appreciable MLR-inhibitory activity. Two active components, 22I and 103I, were purified from the extracts of Bacillus sp. SP22 and Alteromonas sp. RS103, respectively, by successive silica gel column chromatographies. The structure of 22I was estimated to be phosphatidic acid containing saturated isofatty acids (C14:0-C17:0). 103I consisted of phosphatidylglycerol with saturated isofatty acids (C15:0-C18:0). 22I (0.01-1 μg/ml)and 103I (1-10 μg/ml) significantly inhibited MLR in a dose-dependent manner but did not inhibit mitogen-induced proliferation of lymphocytes, unlike cyclosporin A. They did not show any cytotoxicity against mouse splenocytes. L-α-Phosphatidic acid dipalmitoyl, L-α-phosphatidic acid prepared from egg yolk lecithin, and L-α-phosphatidylglycerol dipalmitoyl showed no MLR-inhibitory activity. Isofatty acid-containing phospholipids decreased plasma membrane fluidity of adherent splenocytes and lymphoid neoplasma cell line P388-D1 cells at concentrations with MLR-inhibitory activity, while nonadherent splenocytes were not affected. Daily subcutaneous injection of 221 or 1031 (1 mg/kg/day) resulted in significant suppression of skin-graft rejection between mice with histocompatibility differences. The results suggest that isofatty acid-containing phospholipids suppress the immune responses via the direct action on adherent splenocytes such as macrophages.

AB - Lipid extracts of marine bacterial strains isolated from seawater and sediments from Japanese coasts were screened for inhibition of mouse mixed lymphocyte reaction (MLR). Two strains, Bacillus sp. SP22 and Alteromonas sp. RS103, were found to contain appreciable MLR-inhibitory activity. Two active components, 22I and 103I, were purified from the extracts of Bacillus sp. SP22 and Alteromonas sp. RS103, respectively, by successive silica gel column chromatographies. The structure of 22I was estimated to be phosphatidic acid containing saturated isofatty acids (C14:0-C17:0). 103I consisted of phosphatidylglycerol with saturated isofatty acids (C15:0-C18:0). 22I (0.01-1 μg/ml)and 103I (1-10 μg/ml) significantly inhibited MLR in a dose-dependent manner but did not inhibit mitogen-induced proliferation of lymphocytes, unlike cyclosporin A. They did not show any cytotoxicity against mouse splenocytes. L-α-Phosphatidic acid dipalmitoyl, L-α-phosphatidic acid prepared from egg yolk lecithin, and L-α-phosphatidylglycerol dipalmitoyl showed no MLR-inhibitory activity. Isofatty acid-containing phospholipids decreased plasma membrane fluidity of adherent splenocytes and lymphoid neoplasma cell line P388-D1 cells at concentrations with MLR-inhibitory activity, while nonadherent splenocytes were not affected. Daily subcutaneous injection of 221 or 1031 (1 mg/kg/day) resulted in significant suppression of skin-graft rejection between mice with histocompatibility differences. The results suggest that isofatty acid-containing phospholipids suppress the immune responses via the direct action on adherent splenocytes such as macrophages.

UR - http://www.scopus.com/inward/record.url?scp=8844245749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844245749&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:8844245749

VL - 4

SP - 131

EP - 137

JO - Journal of Marine Biotechnology

JF - Journal of Marine Biotechnology

SN - 0941-2905

IS - 3

ER -